Gene Page: KCNJ13
Summary ?
GeneID | 3769 |
Symbol | KCNJ13 |
Synonyms | KIR1.4|KIR7.1|LCA16|SVD |
Description | potassium voltage-gated channel subfamily J member 13 |
Reference | MIM:603208|HGNC:HGNC:6259|Ensembl:ENSG00000115474|HPRD:04441|Vega:OTTHUMG00000153292 |
Gene type | protein-coding |
Map location | 2q37 |
Pascal p-value | 3.705E-8 |
eGene | Myers' cis & trans |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
LK:YES | Genome-wide Association Study | This data set included 99 genes mapped to the 22 regions. The 24 leading SNPs were also included in CV:Ripke_2013 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs7541471 | chr1 | 39034942 | KCNJ13 | 3769 | 2.001E-5 | trans | ||
rs16825217 | chr1 | 39039168 | KCNJ13 | 3769 | 0.01 | trans | ||
rs7541200 | chr1 | 181327476 | KCNJ13 | 3769 | 5.099E-5 | trans | ||
rs1220293 | 0 | KCNJ13 | 3769 | 0.03 | trans | |||
rs7425100 | chr2 | 136967790 | KCNJ13 | 3769 | 0.05 | trans | ||
rs295936 | chr5 | 58865856 | KCNJ13 | 3769 | 0.01 | trans | ||
rs1919808 | chr7 | 53858331 | KCNJ13 | 3769 | 0.15 | trans | ||
rs4744737 | chr9 | 71533907 | KCNJ13 | 3769 | 0.18 | trans | ||
rs10999109 | chr10 | 71816498 | KCNJ13 | 3769 | 0.1 | trans | ||
rs3750769 | chr10 | 71859865 | KCNJ13 | 3769 | 0.01 | trans | ||
rs11016704 | chr10 | 128989145 | KCNJ13 | 3769 | 0.01 | trans | ||
rs7960377 | chr12 | 19173506 | KCNJ13 | 3769 | 0.18 | trans | ||
rs4787772 | chr16 | 25855167 | KCNJ13 | 3769 | 2.216E-4 | trans | ||
rs1824248 | chr18 | 31073821 | KCNJ13 | 3769 | 0 | trans | ||
rs6051387 | chr20 | 2761097 | KCNJ13 | 3769 | 0.18 | trans | ||
rs17644136 | chr20 | 16000248 | KCNJ13 | 3769 | 0.1 | trans | ||
rs16979011 | chr21 | 28154453 | KCNJ13 | 3769 | 0.12 | trans | ||
rs2830502 | chr21 | 28157753 | KCNJ13 | 3769 | 0.12 | trans | ||
rs17255719 | chrX | 12144766 | KCNJ13 | 3769 | 0.01 | trans | ||
rs4893621 | chrX | 51993653 | KCNJ13 | 3769 | 0.12 | trans | ||
rs12395234 | chrX | 52617968 | KCNJ13 | 3769 | 0.08 | trans | ||
rs6568279 | 0 | KCNJ13 | 3769 | 0.1 | trans | |||
rs12556892 | chrX | 93417735 | KCNJ13 | 3769 | 0 | trans | ||
rs808754 | chrX | 93438033 | KCNJ13 | 3769 | 0 | trans | ||
rs6529399 | chrX | 128763582 | KCNJ13 | 3769 | 0.1 | trans | ||
rs1151982 | chrX | 144618737 | KCNJ13 | 3769 | 0.01 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
GREGORY SYNTHETIC LETHAL WITH IMATINIB | 145 | 83 | All SZGR 2.0 genes in this pathway |
WAKABAYASHI ADIPOGENESIS PPARG RXRA BOUND 8D | 882 | 506 | All SZGR 2.0 genes in this pathway |